New Delhi: The Global Fund to Fight AIDS, Tuberculosis, and Malaria (The Global Fund) announced the successful conclusion of the first summit focused on their strategic partnership with India.
The Global Fund-India Summit 2023, coming on the heels of the G20 health ministers meeting from August 18-19 in Gujarat, served as a platform for discussions, knowledge sharing, and strategic planning with the goal to scale Indian health care solutions globally, particularly those related to health products, digital health and TB.
In its efforts to end AIDS, TB and malaria and strengthen health systems, the Global Fund procures health products from manufacturers in India valued at estimated $600 million annually.
India can build on the scale and capacity of its pharmaceutical industry and deliver product innovations while driving closer South-South collaboration. India’s expertise in digital inclusion, public health, pharmaceuticals and sustainable growth can bridge the gap, uniting developing and developed economies.
The event brought together public health actors from the government, private sector leaders and experts from around the world, to reflect on the unique opportunity that India has on the global stage to fight HIV, tuberculosis (TB), malaria and other deadly diseases.
The Global Fund commended the Government of India and the Indian private sector for their extraordinary advances in fighting infectious diseases and aims to help expand Indian solutions on a global scale.
Emphasising the Global Fund’s partnership with India, Lady Roslyn Morauta, Chair, Global Fund said, “Amid vibrant discussions at the G20 Health Ministers Meeting, India’s G20 leadership has been exemplary. Our partnership in India, directly supporting the national programs in HIV, TB and Malaria through grants to government and non-governmental organisations, reflects our commitment as a strategic partner in the fight against these three infectious diseases.”
“Our investments in India are multi-faceted as we not only provide grant funds but also each year procure hundreds of millions of dollars-worth of health products manufactured in India. As the largest multilateral health fund provider, we have saved over 50 million lives since the inception of our partnership. Since the beginning of the COVID-19 pandemic, we have invested an additional US$5 billion to fight the new pandemic and reinforce systems for health,” she added.
ALSO READ: LPG cylinder prices to be cheaper by Rs 200
FIRST Business Portal addressing the potential of business capability of North East Region.
